about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsLabel-free cell phenotypic profiling decodes the composition and signaling of an endogenous ATP-sensitive potassium channel.High-throughput identification and characterization of novel, species-selective GPR35 agonists.Expression, regulation and putative nutrient-sensing function of taste GPCRs in the heart.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.Label-free drug discovery.Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.Compound annotation with real time cellular activity profiles to improve drug discovery.The drug transporter OAT3 (SLC22A8) regulates endogenous metabolite flow through the gut-liver-kidney axis.Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues.Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.The Three Catecholics Benserazide, Catechol and Pyrogallol are GPR35 Agonists.GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling
P2860
Q24605072-ECDF81C3-2A96-4A99-B6E8-3403A5829745Q33595477-5E8AEC86-F436-4680-A58A-C60E167D0CF1Q34520909-02B795E8-4461-4177-AF34-827A9E2BB83BQ34734229-FDCF354E-168D-4453-9F05-B50022EEAA52Q35425244-5EFE583E-01D8-4E0E-BD2D-608472B94466Q37681372-F767EC80-B63F-40C7-B699-67247EEF2AB0Q38366350-4FA58459-947F-48BF-8C45-88011A37C64CQ38389922-37BF3FB0-B981-47A6-AD58-9F5D805B1CEDQ38452129-9AC6D1A2-041E-4F35-BCBD-9C2D4C19A1E8Q38648038-EA2502F2-FB49-4B41-873D-C15D37DD58B3Q39176941-810A1607-3244-4AE6-B16C-93C2314BF57FQ39594022-EF7132DC-190B-46C5-9CDD-B6BF0D9491BDQ39867411-D4DDD959-6A68-44A3-A170-CDCCE370925EQ41401817-0802E385-C1F8-4F46-9F95-51154CA048FEQ42922733-BAE9A4B8-B4FF-4646-B956-174370D3904EQ47606629-CFCB6A6B-05A4-4199-B229-71CE71148B01Q48423432-BA366FF3-E382-42E3-99EB-4232EDBDD86DQ55497820-C5AED84C-0D08-48F1-84C8-B0D6B2195014Q57069397-9C7CD756-CC8B-4052-8E47-6BDCA9B2D84A
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multiple tyrosine metabolites are GPR35 agonists.
@en
Multiple tyrosine metabolites are GPR35 agonists.
@nl
type
label
Multiple tyrosine metabolites are GPR35 agonists.
@en
Multiple tyrosine metabolites are GPR35 agonists.
@nl
prefLabel
Multiple tyrosine metabolites are GPR35 agonists.
@en
Multiple tyrosine metabolites are GPR35 agonists.
@nl
P2860
P356
P1433
P1476
Multiple tyrosine metabolites are GPR35 agonists.
@en
P2093
Huayun Deng
P2860
P2888
P356
10.1038/SREP00373
P407
P50
P577
2012-04-20T00:00:00Z